Bangalore, India: There have been some inaccurate media reports about Merck’s product Nasivion featuring in the banned drug list. Merck a leading science and technology company, is clarifying that products under Nasivion brand does not fall under the banned drug list in the recently published list of banned FDCs released by DCGI on 10th of March 2016.
Nasivion brand marketed by Merck has Nasivion Nasal Drops, Nasivion Tablets and Nasivion Care Nasal Drops under its umbrella.
Merck has all the requisite approvals for Nasivion tabs (DCGI approved FDC in October 2010), Nasivion care drops (DCGI approved FDC in 2015), Nasivion drops – Classic Adults, Paediatric and Mini (Not FDCs and so never under question by DCGI during the FDC approval exercise).
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2015, Merck generated sales of € 12.85 billion in 66 countries.
Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.